DHT Blocker Side Effects on Females: What to Know

DHT blocker side effects on females can include changes in sexual desire, breast symptoms, and scalp irritation. Related antiandrogen treatments can also affect menstrual cycles, blood pressure, and potassium levels. The treatment, dose, formulation, and a woman’s overall health and reproductive plans determine which potential risks deserve attention.[2, 6, 7]

When choosing a DHT blocker for women, consider both its effects on hair follicles and its potential hormonal effects throughout the body. Prescription medications, botanical supplements, and scalp treatments each require an assessment of their ingredients, exposure, and supporting research.

This guide explains how DHT blockers work, what studies in women report, and the precautions that matter when selecting a treatment or hair-care routine.

What is DHT in women?

Dihydrotestosterone, or DHT, is an androgen formed when the enzyme 5α-reductase converts testosterone into DHT. Women produce androgens through the ovaries, adrenal glands, and conversion in peripheral tissues. These hormones participate in normal physiology, including sexual function and skin and hair biology.[1, 2]

In susceptible scalp follicles, androgen signaling can contribute to miniaturization: follicles progressively produce finer hairs, and visible coverage decreases. The effects of DHT on the scalp depend on follicular sensitivity, genetics, age, and other biological factors. Our Hair Biology guide explains how hormonal signals interact with follicle structure and the growth cycle.

Female pattern hair loss can occur with normal circulating androgen levels. A widening part, reduced crown density, or persistent hair thinning warrants an assessment of the hair-loss pattern, relevant medical history, and hormonal changes. Testing hormone levels can help investigate suspected androgen excess. Acne, irregular periods, and increased facial or body hair can prompt evaluation for androgen excess, including polycystic ovary syndrome (PCOS).[1]

Learn more about follicular miniaturization in our guide to androgenetic alopecia and pattern hair loss.

What is a DHT blocker for women?

A DHT blocker reduces DHT production or is marketed for its potential to influence the DHT pathway. Hair-loss treatment also includes antiandrogens that reduce androgen-receptor signaling.

Treatment options include:

• Finasteride and dutasteride: prescription 5α-reductase inhibitors that reduce DHT formation.
• Spironolactone: an antiandrogen used in selected women with hair loss. It also affects fluid balance, blood pressure, and potassium regulation.
• Botanical supplements: ingredients such as saw palmetto and pumpkin seed oil studied for potential effects on androgen pathways and hair growth.
• Topical medications and botanical hair care: scalp-applied preparations, including leave-on treatments and DHT-focused shampoos.[2, 7, 10, 15]

Clinicians use finasteride and dutasteride as DHT blockers for women and prescribe spironolactone as a related antiandrogen. These medicines are used off-label for female pattern hair loss. Selection requires attention to diagnosis, reproductive plans, medical history, and treatment-specific evidence.[15, 16]

How do DHT blockers work?

Reducing testosterone’s conversion to DHT

Finasteride primarily inhibits type II 5α-reductase. Dutasteride inhibits types I and II. As oral blockers, these medicines reduce DHT levels and can reduce androgen stimulation of susceptible follicles.[2, 7]

Female treatment findings vary with dose and study population. A randomized trial of 137 postmenopausal women found similar hair outcomes with finasteride 1 mg daily and placebo over 12 months. Higher-dose observational studies have reported improvement in some women, supporting individualized prescribing and careful interpretation of the evidence.[3, 4]

Reducing androgen-receptor signaling

Spironolactone reduces androgen activity through receptor antagonism and other antiandrogen effects. Its additional action on mineralocorticoid receptors explains important considerations involving blood pressure, kidney function, and potassium.[15]

Botanical activity

Plant extracts contain compounds that can interact with enzymes and other biological pathways. Saw palmetto has antiandrogenic properties, and laboratory research has examined potential 5α-reductase inhibition by botanical compounds. Evidence assessment should identify the extract, concentration, delivery route, and outcomes measured.[10, 12, 13]

Are DHT blockers safe for women?

DHT blockers can be appropriate for selected women under clinical supervision. A safety assessment considers the expected benefit, the treatment’s adverse effects, pregnancy potential, other medications, and the monitoring required. Your healthcare provider can use these findings to develop an individualized treatment plan.[1, 16]

For a woman with progressive pattern hair loss, a clinician can assess whether an androgen-directed treatment belongs in the plan. Clinical guidance also places topical minoxidil among the principal treatments for female pattern hair loss; its hair-growth mechanism provides a separate treatment pathway.[1, 15]

Pregnancy, breastfeeding, conception planning, kidney or liver disease, and previous adverse reactions deserve specific discussion. Hormonal effects require careful consideration with medications and botanicals, including products marketed for scalp use.

Our broader guide to DHT blocker side effects in medications and shampoos provides additional context across treatment categories.

DHT blocker side effects in women: prescription options and botanical products

What female studies report about side effects

Reduced libido and sexual symptoms

Reduced sexual desire has been reported in women taking finasteride. In a study of 40 postmenopausal women taking 5 mg daily for 18 months, 4 women reported maintained libido reduction—10% of the study group. One participant also had elevated liver enzymes.[4]

This was a small, uncontrolled study. Its findings describe that specific dose and population; the precision of an individual woman’s risk estimate remains limited.

Changes in sexual desire deserve clinical review, particularly when they begin after treatment starts or a dose changes. A review can consider medication exposure alongside menopausal symptoms, other prescriptions, and relevant health factors.

Menstrual irregularities and breast symptoms

These effects require treatment-specific attribution. A 2025 randomized pilot trial enrolled 48 premenopausal women and compared spironolactone 100 mg daily with placebo for 24 weeks. Both groups used topical minoxidil. Menstrual irregularities occurred in 37.5% of participants receiving spironolactone.[6]

Finasteride safety reviews also describe reports of breast tenderness or swelling and menstrual changes. Reliable frequency estimates for women remain limited.[7]

New menstrual changes, breast symptoms, dizziness, or weakness warrant review with the prescribing clinician. Spironolactone monitoring should reflect kidney function, age, other medications, and potassium-related risk factors.[15]

Mood changes

Finasteride pharmacovigilance research has identified reporting signals involving depression, anxiety, and suicidality. These findings support attention to psychiatric symptoms. Female-specific frequency estimates and the contribution of treatment to an individual symptom remain uncertain.[8]

Discuss a history of depression or anxiety before treatment. Seek prompt medical advice for new or worsening mood symptoms, and urgent help for thoughts of self-harm.

Scalp irritation and allergic reactions

Shampoos and scalp treatments can cause itching, burning, redness, scaling, or allergic contact dermatitis. Potential triggers include botanical ingredients, fragrances, preservatives, and surfactants.[17]

Persistent symptoms deserve a dermatologic assessment. A dermatologist can evaluate the scalp and use patch testing when appropriate to identify contact allergens. Bring the product and complete ingredient list to the appointment.[17]

Can topical DHT blockers have systemic effects?

Scalp-applied ingredients can enter the circulation. The extent of exposure depends on the active ingredient and formulation, with application amount, frequency, contact time, and scalp condition also relevant to assessment.

A randomized study of 30 postmenopausal women evaluated 0.25% topical finasteride combined with 3% minoxidil over 24 weeks. The combination group had a statistically significant reduction in serum DHT, demonstrating a measurable systemic hormonal effect with that preparation.[5]

Systemic side effects deserve attention when evaluating scalp-applied treatments. Botanical scalp products require their own exposure assessment. Ingredients researched for hormonal activity warrant attention to concentration, delivery, and the complete routine. Clinical evaluation should include shampoos, leave-on treatments, and oral supplements used together.

How do DHT-blocking shampoos work?

DHT-focused shampoos combine cleansing with ingredients selected for potential effects on androgen pathways or the scalp environment.

The cleansing system removes oil and residue. During washing, botanical ingredients contact the scalp, and their delivery depends on the formulation and use conditions. Proposed DHT-related activity involves compounds that may influence 5α-reductase or other androgen pathways; some formulas also contain ingredients researched for antioxidant or anti-inflammatory activity.[10, 12, 13]

Assess a DHT-focused shampoo through its complete formula and supporting studies. The most useful evidence measures the finished product’s effects on hair, scalp tolerability, and hormonal exposure where relevant. Ingredient studies provide a starting point for understanding the biological rationale.

When choosing a DHT-focused shampoo, consider scalp health and comfort alongside its ingredients, directions, contact time, and compatibility with other treatments. Hormonal or reproductive concerns deserve discussion with a clinician.

Botanical DHT blockers: what research suggests

Research into natural alternatives includes pumpkin seed oil, saw palmetto, and green tea compounds. The sections below describe the evidence for each ingredient.

Pumpkin seed oil

Pumpkin seed oil contains fatty acids and phytosterols. Preclinical research has examined antiandrogenic activity and potential effects on 5α-reductase.[12]

A randomized comparative trial assigned 60 women with female pattern hair loss to topical pumpkin seed oil or 5% minoxidil foam for three months. The pumpkin seed oil group showed improvements in several dermoscopic measures, including hair-shaft diversity and regrowing hairs.[11]

These findings support further research into topical pumpkin seed oil. The study evaluated hair outcomes over a short period; women-specific hormonal exposure, longer-term safety, and pregnancy and breastfeeding safety remain important research questions.

Saw palmetto

Saw palmetto (Serenoa repens) contains fatty acids and sterols and is studied for antiandrogenic properties. A systematic review reported promising hair findings across several oral and topical preparations. The evidence includes varied formulations and study designs, with further research needed to define long-term outcomes and the contribution of saw palmetto itself.[10]

Learn more in our physician’s review of saw palmetto for hair loss.

Green tea compounds

Laboratory research has identified 5α-reductase-inhibitory activity involving certain green tea polyphenols, including epigallocatechin gallate (EGCG). This is mechanistic evidence from experimental conditions. Human research evaluating female hair outcomes, formulation-specific hormonal effects, and reproductive safety remains limited.[13]

Our guide to natural DHT blockers and hair loss explores additional ingredient research.

Pregnancy, breastfeeding, and trying to conceive

Review every product with known or suspected DHT-blocking or hormonal activity with your clinician before starting or continuing it during pregnancy, breastfeeding, or conception planning. This includes prescription medicines, supplements, botanical shampoos, and leave-on scalp treatments.

Pregnancy and conception planning

Finasteride and dutasteride are contraindicated during pregnancy because inhibition of DHT formation can disrupt androgen-dependent fetal development. Animal studies document birth defects affecting male external genitalia. For women of childbearing age, prescription antiandrogen treatment requires an appropriate pregnancy-prevention plan when pregnancy is possible.[7]

Discuss contraception, planned conception, and discontinuation timing with the prescriber. Dutasteride’s prolonged persistence makes advance planning especially important. Review botanical ingredients with suspected androgen effects through the same clinical discussion, using the complete formula and directions. Pregnant women who have used an androgen-directed treatment should contact their clinician for an exposure assessment.[7, 10]

Breastfeeding

Breastfeeding assessment considers maternal absorption, transfer into milk, infant exposure, and the specific treatment. A 2025 review in the International Journal of Dermatology emphasizes treatment-by-treatment evaluation of alopecia therapies during lactation.[9]

Your clinician should assess the full routine, including oral supplements, shampoos, and leave-on products. Products with known or suspected hormonal activity require an explicit review of the available evidence and alternatives.

Looking for DHT-blocker-free hair care?

When choosing DHT-blocker-free hair care, review the complete ingredient list for compounds with known or suspected androgen-modulating activity. Bring the formula to your clinician when pregnancy, breastfeeding, conception planning, or hormonal sensitivity guides your choice.

Origenere’s La Rosa Collection is formulated without DHT blockers and focuses on strand softness, conditioning, and manageability. It provides a clear option for women seeking DHT-blocker-free shampoo, conditioner, and hair tonic. During pregnancy and breastfeeding, review the individual product’s complete formula with your provider.

When choosing a DHT-focused treatment or shampoo

A useful clinical discussion covers five questions:

1. What is causing the hair loss? Review the pattern, onset, scalp findings, medications, hormonal symptoms, and relevant laboratory testing.
2. What evidence supports this treatment for women? Review oral and topical options, identifying the studied population, dose, route, and duration.
3. Which side effects require monitoring? Establish a plan for sexual symptoms, menstrual changes, breast symptoms, mood, scalp reactions, and treatment-specific laboratory checks.
4. How does the complete routine affect exposure? Include prescriptions, supplements, shampoos, and leave-on products.
5. How will progress be assessed? Use standardized photographs to track changes in hair density and signs of hair regrowth. Agree on follow-up intervals that account for consistent use, the treatment studied, and tolerability.

Hair response develops over months. The scalp’s anagen growth phase usually lasts several years, and treatment assessment reflects gradual changes in growth and visible density. Our hair growth cycle guide explains these stages.[14]

Choosing a botanical hair-care routine

Origenere’s Naturale Purity Collection includes botanical hair care with formula-specific ingredients such as saw palmetto. The Sempre Hair Growth System includes products featuring the proprietary TR6™ botanical complex.

Review each product’s ingredient list and directions with attention to its place in the complete routine. When hormonal activity is a concern, discuss the formulation and available evidence with your clinician.

Our shampoo selection guide explains the different hair-care approaches.

Frequently asked questions

Can women take DHT blockers for hair loss?

Yes. Clinicians prescribe androgen-directed treatments for selected women with female pattern hair loss. The choice depends on diagnosis, reproductive plans, health history, and the evidence for the specific treatment.[1, 16]

What are the main DHT blocker side effects on females?

Reported effects include reduced libido, breast symptoms, and local scalp reactions. Spironolactone can also cause menstrual irregularities and affect blood pressure and potassium. Pregnancy precautions are central to prescription antiandrogen treatment.[4, 6, 7, 15]

Can DHT blockers lower libido in women?

Reduced libido has been reported with oral finasteride. One small study reported maintained libido reduction in 4 of 40 postmenopausal women taking 5 mg daily for 18 months. Interpretation should retain that dose, population, and study design.[4]

Are natural DHT blockers safe for women?

Safety requires an ingredient- and formulation-specific assessment. Botanical extracts can have biological activity, cause adverse reactions, and warrant reproductive precautions. Review the full formula and available evidence, especially when taking other treatments or planning pregnancy.[10, 17]

Can a DHT-blocking shampoo affect hormones?

Potential hormonal effects depend on the ingredients and systemic exposure. A responsible assessment considers the finished formula, concentration, use conditions, and available absorption or hormone measurements. Discuss shampoos containing known or suspected hormonally active ingredients with your clinician when hormonal exposure is a concern.

Can women combine oral and topical treatments?

Clinicians sometimes use combination treatment for female pattern hair loss. Review all active ingredients together to assess overlapping exposure, interactions, scalp tolerability, and the monitoring required.[15]

References

1. Carmina E, et al. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Journal of Clinical Endocrinology & Metabolism. 2019. https://pubmed.ncbi.nlm.nih.gov/30785992/
2. Iamsumang W, et al. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug Design, Development and Therapy. 2020. https://pubmed.ncbi.nlm.nih.gov/32184564/
3. Price VH, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Journal of the American Academy of Dermatology. 2000. https://pubmed.ncbi.nlm.nih.gov/11050579/
4. Oliveira-Soares R, et al. Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women. International Journal of Trichology. 2013. https://pubmed.ncbi.nlm.nih.gov/23960392/
5. Suchonwanit P, et al. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study. American Journal of Clinical Dermatology. 2019. https://pubmed.ncbi.nlm.nih.gov/30206824/
6. Werachattawatchai P, et al. Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study. International Journal of Women’s Dermatology. 2025. https://pubmed.ncbi.nlm.nih.gov/40978669/
7. Hirshburg JM, et al. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. Journal of Clinical and Aesthetic Dermatology. 2016. https://pmc.ncbi.nlm.nih.gov/articles/PMC5023004/
8. Nguyen DD, et al. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. JAMA Dermatology. 2021. https://pubmed.ncbi.nlm.nih.gov/33175100/
9. Needle CD, et al. Alopecia Treatments in Breastfeeding: Safety and Clinical Considerations. International Journal of Dermatology. 2025. https://pubmed.ncbi.nlm.nih.gov/40629555/
10. Evron E, et al. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia. Skin Appendage Disorders. 2020. https://pubmed.ncbi.nlm.nih.gov/33313047/
11. Ibrahim IM, et al. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial. Journal of Cosmetic Dermatology. 2021. https://pubmed.ncbi.nlm.nih.gov/33544448/
12. Cho YH, et al. Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial. Evidence-Based Complementary and Alternative Medicine. 2014. https://pubmed.ncbi.nlm.nih.gov/24864154/
13. Hiipakka RA, et al. Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochemical Pharmacology. 2002. https://pubmed.ncbi.nlm.nih.gov/11931850/
14. Avci P, et al. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers in Surgery and Medicine. 2014. https://pubmed.ncbi.nlm.nih.gov/23970445/
15. Ramos PM, et al. Female-pattern hair loss: therapeutic update. Anais Brasileiros de Dermatologia. 2023. https://pubmed.ncbi.nlm.nih.gov/37003900/
16. Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current and emerging therapies. Journal of the American Academy of Dermatology. 2025. https://pubmed.ncbi.nlm.nih.gov/40345536/
17. Potential for Allergic Contact Dermatitis in Popular Hair Care Practices and Ingredients. Dermatitis. 2023. https://pubmed.ncbi.nlm.nih.gov/37339433/